切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Farnesoid X receptors (FXRs) - Myosin light chain kinases (MLCKs) - IDH2 - Calcium-Activated Potassium (KCa) Channels

10 件产品

每页
清除全部
  1. Obeticholic Acid
    B4888 Obeticholic Acid
     2 Citation
    中文名: 奥贝胆酸
    Target: Farnesoid X receptors (FXRs)
    Summary: FXR激动剂
      ≥21.5 mg/mL
      insoluble in H2O
  2. H-7 dihydrochloride
    B6342 H-7 dihydrochloride
    Target: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)
    Summary: 蛋白激酶抑制剂
      Soluble in DMSO
  3. Fasudil
    B3523 Fasudil
    中文名: 法舒地尔
    Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)
    Summary: 钙拮抗剂
      Soluble in DMSO
  4. Dequalinium Chloride
    B2191 Dequalinium Chloride
    中文名: 地喹氯铵
    Target: PKC|Calcium-Activated Potassium (KCa) Channels
    Summary: PKC抑制剂
      insoluble in DMSO
      insoluble in H2O
  5. XL335
    B1528 XL335
    Target: Farnesoid X receptors (FXRs)
    Summary: FXR激动剂
      ≥20.4 mg/mL
      insoluble in H2O
  6. Lithocholic Acid
    A8463 Lithocholic Acid
    中文名: 石胆酸
    Target: Farnesoid X receptors (FXRs)|Vitamin D receptors (VDRs)|Pregnane X receptor(PXR)
    Summary: 维生素D受体PXR和FXR的激活剂
      ≥12.95 mg/mL
      insoluble in H2O
  7. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O
  8. TRAM-34
    A1888 TRAM-34
    Target: Calcium-Activated Potassium (KCa) Channels
    Summary: KCa3.1阻断剂
      ≥17.25 mg/mL
      insoluble in H2O
  9. ML-7 hydrochloride
    A3626 ML-7 hydrochloride
    Target: Myosin light chain kinases (MLCKs)
    Summary: 肌球蛋白轻链激酶抑制剂
      ≥15.95 mg/mL
      ≥8.82 mg/mL
  10. AGI-6780
    A3146 AGI-6780
    Target: IDH2
    Summary: IDH2/R140Q突变抑制剂
      ≥22.25 mg/mL
      insoluble in H2O

10 件产品

每页